$0.5117
0[-0.01%]
Last update: 7:34AM Get Real Time Here
Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | SLRX | Q1 | -$2.23 | -$6.70 | — | — | $0.00 | — | — | — | Get Alert |
03/22/2024 | PM | SLRX | Q4 | -$2.83 | -$1.01 | -$0.22 | 78.22% | $0.00 | — | $0.00 | — | Get Alert |
11/09/2023 | PM | SLRX | Q3 | -$2.47 | -$1.20 | -$0.65 | 45.83% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2023 | PM | SLRX | Q2 | -$2.25 | -$1.30 | -$1.43 | -10.00% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2023 | AM | SLRX | Q1 | -$3.30 | -$2.59 | -$2.23 | 13.90% | $0.00 | — | $0.00 | — | Get Alert |
03/27/2023 | AM | SLRX | Q4 | -$2.27 | -$2.15 | -$2.83 | -31.63% | $0.00 | — | $0.00 | — | Get Alert |
11/10/2022 | AM | SLRX | Q3 | -$2.09 | -$2.55 | -$2.47 | 3.14% | $0.00 | — | $0.00 | — | Get Alert |
08/05/2022 | PM | SLRX | Q2 | -$1.75 | -$2.50 | -$2.25 | 10.00% | $571.39K | — | $0.00 | — | Get Alert |
05/12/2022 | PM | SLRX | Q1 | -$1.50 | -$2.25 | -$3.25 | -44.44% | $1.27M | — | $0.00 | — | Get Alert |
03/10/2022 | PM | SLRX | Q4 | -$2.50 | -$2.00 | -$2.25 | -12.50% | $1.48M | $430.00K | $0.00 | -100.00% | Get Alert |
11/04/2021 | PM | SLRX | Q3 | -$2.50 | -$1.50 | -$2.00 | -33.33% | $1.38M | $1.16M | $0.00 | -100.00% | Get Alert |
08/05/2021 | AM | SLRX | Q2 | -$3.25 | -$1.50 | -$1.75 | -16.67% | $1.24M | $1.28M | $571.39K | -55.36% | Get Alert |
05/12/2021 | PM | SLRX | Q1 | -$5.50 | -$1.25 | -$1.50 | -20.00% | $1.13M | $1.37M | $1.27M | -7.37% | Get Alert |
03/18/2021 | PM | SLRX | Q4 | -$11.00 | -$2.75 | -$2.50 | 9.09% | $1.04M | $1.48M | $1.48M | -0.07% | Get Alert |
11/11/2020 | PM | SLRX | Q3 | -$18.25 | -$2.50 | -$2.50 | 0.00% | $874.95K | $1.34M | $1.38M | 2.84% | Get Alert |
08/12/2020 | PM | SLRX | Q2 | -$50.00 | — | -$3.25 | — | $164.71K | $1.19M | $1.24M | 4.45% | Get Alert |
05/14/2020 | PM | SLRX | Q1 | -$3.00 | — | -$5.50 | — | $105.00K | $5.52M | $1.13M | -79.47% | Get Alert |
03/23/2020 | PM | SLRX | Q4 | -$2.75 | — | -$11.00 | — | $163.00K | — | $1.04M | — | Get Alert |
11/13/2019 | AM | SLRX | Q3 | -$3.75 | — | -$18.25 | — | $469.05M | — | $874.95K | — | Get Alert |
Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 22, 2024 for Q4.
The Actual EPS was $-0.22, which beat the estimate of $-1.01.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.